Inside the research

AdaptHealth Corp.

AHCO Research profile · latest available data

Price overview

$5.64

▲ +0.07 (+1.3%)

52w hi$13.38
52w lo$5.22
Vol1.35M
As of25 Sep 2026

The Verdict

Hold

Our score -0.46

Short-0.43
Medium-0.42
Long-0.61

computed 2026-09-27

Key fundamentals

AdaptHealth Corp.

Healthcare · Medical Devices

Market cap$752.43M
Enterprise value$2.78B
Forward P/E-45.48x
EV / EBITDA4.77x
P / S (ttm)0.23x
Profit margin-6.8%
Return on equity-15.2%
Revenue growth+12.7%
Debt / equity148.97

Layer Breakdown

LayerRawContribution
Fundamental-0.05
Sector+0.08
Technical-0.36
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.

United States · adapthealth.com

Risk Metrics

Beta vs SPX0.65
Corr SPX0.18
Annual vol57.8%
Annual ret-16.8%
Sharpe-0.29
Max DD-61.0%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$14.00
High / Low$18.00 / $11.00
Median$14.00
Analysts8
Strong Buy1
Buy5
Hold2
Sell0
Strong Sell0

Recent rating actions

2026-05-06UBS→ Buy
2026-05-06Canaccord Genuity→ Buy
2026-04-13Truist Securities→ Buy
2026-02-26Leerink Partners→ Outperform
2025-11-06Canaccord Genuity→ Buy
2025-05-12Truist Securities→ Buy

Material Events

DateEvent8-K
2026-08-04Earnings Release, Exhibitsread
2026-07-20Material Agreement, Exhibitsread
2026-07-07Reg FD Disclosureread
2026-07-021.05read
2026-06-22Shareholder Voteread
2026-05-05Earnings Release, Officer / Director Change…read
2026-04-13Material Agreement, Termination of Agreement…read
2026-02-24Earnings Release, Exhibitsread
2025-11-04Earnings Release, Exhibitsread
2025-08-05Earnings Release, Exhibitsread
2025-08-05Reg FD Disclosure, Exhibitsread
2025-06-30Reg FD Disclosure, Exhibitsread

Flow & Concentration

Insider 180d net$0
Insider buys / sells0 / 0
Insider biasNeutral
13F holders8
Top-5 share95.8%
HHI3,633 (concentrated)

Top Holders

HolderValueShares
Fidelity / FMR LLC$82.14M7.88M
State Street Corp$48.24M4.63M
Renaissance Technologies$7.96M764.34K
AQR Capital Management$7.94M761.86K
Citadel Advisors$6.70M643.25K
Millennium Management$3.63M347.92K
Capital Research / Capital World$3.10M297.04K
T. Rowe Price Group$1.32K127.04K

As of 2026-06-30

SEC Filings

DateFormDoc
2026-08-104view
2026-08-104view
2026-08-0410-Qview
2026-08-048-Kview
2026-07-208-Kview
2026-07-078-Kview
2026-07-064view
2026-07-028-Kview
2026-06-264view
2026-06-264view
2026-06-264view
2026-06-264view
2026-06-264view
2026-06-264view
2026-06-264view

The Long Run

FY 2018–2025 · 8 years

LineLatestCAGRTrend
Revenue$3.26B+35.4%
Operating income$90.87M+19.6%
Net income-$678.89M+198.0%
Cash from ops$480.67M+38.4%

Indices

S&P SmallCap 600

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$5.58$5.66$5.52$5.641.35M
Sep 24$5.65$5.76$5.56$5.572.10M
Sep 23$5.77$5.81$5.64$5.701.99M
Sep 22$5.79$5.89$5.72$5.772.76M
Sep 21$5.74$5.89$5.59$5.752.78M

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →